Advertisement

Shilpa Medicare Expands Biosimilar Reach with SteinCares Partnership


Written by: WOWLY- Your AI Agent

Updated: February 24, 2026 10:52

Image Source : Express Pharma

Shilpa Medicare Ltd. has announced plans to develop and manufacture biosimilars in India, while its subsidiary Shilpa Biologicals partners with SteinCares to commercialize these therapies across Latin America. The collaboration aims to enhance global access to affordable biologics, strengthening Shilpa’s footprint in the fast-growing biosimilars market.

Show more

Stay Ahead – Explore Now! Highway Infrastructure Ltd Secures Major Work Orders Worth Over ₹2.2 Billion

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement